Skip to main content
HR 6062 116th Congress House Health Drug safety, medical device, and laboratory regulation Health technology, devices, supplies

To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with…

Show full title

To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes.

Introduced: March 3, 2020 Introduced by: Schneider, Bradley Scott Democratic · Illinois See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 4, 2020
Sponsor introductory remarks on measure. (CR H1476)
Mar 3, 2020
Referred to the House Committee on Energy and Commerce.
Mar 3, 2020
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This bill expands existing requirements relating to supply shortages of life-saving drugs to also apply to life-saving medical devices.

Generally, a manufacturer must (1) notify the Food and Drug Administration (FDA) of supply interruptions in certain circumstances, (2) provide for the expedited review of a new device that may mitigate the shortage, and (3) allow the FDA to authorize the importation of the device for emergency medical care.

What's happening now March 4, 2020

Sponsor introductory remarks on measure. (CR H1476)

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 1
Hice, Jody
· Mar 3, 2020
 D
Schakowsky, Janice D.
Illinois · Mar 3, 2020
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6062: To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes.. 116th Congress. Open America. https://openamerica.io/bill/116-HR-6062/
MLA
"H.R. 6062: To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes.." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-6062/.
Bluebook (legal)
H.R. 6062, 116th Cong. (2026), https://openamerica.io/bill/116-HR-6062/.
Markdown link
[H.R. 6062: To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes.](https://openamerica.io/bill/116-HR-6062/)
Report a problem